Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

The lights at several intersections will now include a phase where all the lights stay red, giving pedestrians the right of way in every direction.

Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...

Caregivers should understand the phases of mental health recovery so they can recognize signs, strengthen bonds, and support ...

A nanoscale optical device has been developed that allows independent control over the intensity and phase of light. By ...

The Center for Reproductive Health, University of Edinburgh reports that long COVID was associated with abnormal uterine ...

Genmab acquires Merus for $8B, boosting cancer drug pipeline with petosemtamab. Check out what this deal means for GMAB and ...

Extending our trial with more compatible devices, and more to stream.

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...

An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an ...

Combination therapy with relatlimab and nivolumab enhances treatment-free survival in advanced melanoma, offering promising ...